Bioengineered liposome-scaffold composites as therapeutic delivery systems

Area of Science:

• Biomaterials Science
• Drug Delivery Systems
• Nanotechnology

Background:

• Liposomes are versatile drug carriers but face limitations in stability and targeted delivery.
• Biomaterial scaffolds offer structural support and a conducive environment for tissue regeneration.
• Integrating liposomes with scaffolds presents an opportunity to enhance therapeutic efficacy.

Purpose of the Study:

• To review the key developments in bioengineered liposome-scaffold composites.
• To highlight the synergistic benefits of combining liposomes and biomaterial scaffolds for enhanced therapies.
• To discuss the potential clinical applications of these advanced drug delivery systems.

Main Methods:

• Review of existing literature on liposome-scaffold composite systems.
• Analysis of studies focusing on the integration of liposomes within various biomaterial scaffolds (polymer-based, nanofiber-based).
• Examination of findings related to the enhanced delivery, responsiveness, and potency of these composites.

Main Results:

• Liposome-scaffold composites demonstrate amplified therapeutic potential through enhanced delivery, environmental responsiveness, and potency.
• Scaffolds provide improved physical strength, rheological properties, and a natural environment for tissue formation.
• These composites enable biocompatible delivery of both hydrophilic and lipophilic compounds, with options for functionalization for targeted delivery.
• Various topical, ocular, oral, nasal, and vaginal applications have been explored.

Conclusions:

• Bioengineered liposome-scaffold composites represent a promising multimodal system with significant clinical potential.
• The combination overcomes limitations of individual components, leading to advanced therapeutic strategies.
• Further research into the complexation mechanisms and rheological properties will drive innovation in this field.